Botanical species · safety record

Guazuma ulmifolia

The EFSA Compendium of Botanicals holds 9 constituent measurements and 1 adverse-effect record for Guazuma ulmifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Guazuma ulmifolia Lam.

9Constituent measurements

1Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Dhurrin	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Proanthocyanidins (condensed tannins)	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Taxiphyllin	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Fruit unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Coumarins	Fruit unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Proanthocyanidins (condensed tannins)	Aerial part of plants	Solvent extraction	205.9 Gram/kilogram	Unspecified	No resolvable identifier
Saponins	Fruit unspecified	Solvent extraction	1.59 Percent	Phytochemical screening	No resolvable identifier
Tannins	Fruit unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Leaves	Solvent extraction	14.5 Percent	Unspecified	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Aerial part of plants	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Pizzani, Pablo., Matute, Irana., Martino, Giovanna., Arias, Adelis., Godoy, Susmira., Pereira, Luis., Palma, Jos�., Rengifo, Mercedes. Composici�n Fitoqu�mica y Nutricional de Algunos Frutos de �rboles de Inter�s Forrajero de Los Llanos Centrales de Venezuela . Revista de la facultad de ciencias veterinarias, 2006, vol. 47, no. 2, p. 105-113.
Seigler, DS., Pauli, GF., Frohlich, R., Wegelius, E., Nahrstedt, A., Glander, KE., Ebinger, JE. Cyanogenic glycosides and menisdaurin from Guazuma ulmifolia, Ostrya virginiana, Tiquilia plicata, and Tiquilia canescens. PHYTOCHEMISTRY, 2005, vol. 66, no. 13, p. 1567-1580. DOI
Ortega, ME., Carranco, ME., Mendoza, G., Castro, G. Chemical composition of Guazuma ulmifolia Lam and its potential for ruminant feeding . Cuban journal of agricultural science, 1998, vol. 32, no. 4, p. 383-386.
Hor, M., Heinrich, M., Rimpler, H. Proanthocyanidin polymers with antisecretory activity and proanthocyanidin oligomers from Guazuma ulmifolia bark. PHYTOCHEMISTRY, 1996, vol. 42, no. 1, p. 109-119. DOI
Lopez, Juan., Tejada, Irma., Vasquez, Carlos., de Dios Garza, Juan., Shimada, Armando. Condensed tannins in humid tropical fodder crops and their in vitro biological activity: Part 1. Journal of the science of food and agriculture, 2004, p. 291-294.
Mata, R., Cristians, S., Escand�n-Rivera, S., Ju�rez-Reyes, K., Rivero-Cruz, I. Mexican antidiabetic herbs: Valuable sources of inhibitors of alpha-glucosidases. Journal of natural products, 2013, vol. 76, no. 3, p. 468-483. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature